BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6184148)

  • 1. Identification of a high-molecular-weight nonfunctional protein in L1210 leukemia cells with common antigenic determinants to dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Cancer Res; 1983 Feb; 43(2):529-35. PubMed ID: 6184148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukemia and normal leukocytes contain a species of immunoreactive but nonfunctional dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):645-9. PubMed ID: 6952216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse brain contains a high molecular weight nonfunctional protein with antigenic homology to dihydrofolate reductase.
    Iqbal MP; Rothenberg SP; LaRosa C
    Biochem Biophys Res Commun; 1986 Nov; 141(1):258-62. PubMed ID: 3800999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
    Bertino JR; Cashmore AR; Hillcoat BL
    Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
    Duffy TH; Beckman SB; Huennekens FM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive enzyme-linked immunosorbent assay for dihydrofolate reductase.
    Iqbal MP; Hussain R
    Ital J Biochem; 1991; 40(4):207-15. PubMed ID: 1787054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for kinetic and immunologic heterogeneity of dihydrofolate reductase in L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; da Costa M
    Biochem Med Metab Biol; 1991 Oct; 46(2):196-207. PubMed ID: 1782010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
    Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
    Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonfunctional protein in human leukemia cells reacts with antiserum to dihydrofolate reductase from L1210 leukemia cells.
    Iqbal MP; Rothenberg SP
    Life Sci; 1981 Aug; 29(7):689-96. PubMed ID: 6168882
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a novel reductase in folate metabolism.
    Rothenberg SP; Kyner D; Solomon G
    Mt Sinai J Med; 1992 Mar; 59(2):150-3. PubMed ID: 1574069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate and extent of interconversion of tetrahydrofolate cofactors to dihydrofolate after cessation of dihydrofolate reductase activity in stationary versus log phase L1210 leukemia cells.
    Trent DF; Seither RL; Goldman ID
    J Biol Chem; 1991 Mar; 266(9):5445-9. PubMed ID: 1825999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A; Friedkin M
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct ligand-binding radioassay for the measurement of methotrexate in tissues and biological fluids.
    Arons E; Rothenberg SP; Costa MD; Fischer C; Iqbal MP
    Cancer Res; 1975 Aug; 35(8):2033-8. PubMed ID: 807320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of the bifunctional thymidylate synthase-dihydrofolate reductase complex from the human malaria parasite Plasmodium falciparum.
    Chen GX; Zolg JW
    Mol Pharmacol; 1987 Dec; 32(6):723-30. PubMed ID: 3320742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
    Duffy TH; Sato JK; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 24():13-25. PubMed ID: 3835818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.